Images List Premium Download Classic

Neurological

Neurological-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Dendrimer compositions and use in treatment of neurological and cns disorders
Kennedy Krieger Institute, Inc.
August 17, 2017 - N°20170232120

A dendrimer formation, such as a pamam dendrimer or a multiarm peg polymeric formulation has been developed for systemic administration to the brain or central nervous system. In the preferred embodiment, the dendrimers are in the form of dendrimer nanoparticles comprising poly(amidoamine) (pamam) hydroxyl-terminated dendrimers covalently linked to at least one therapeutic, prophylactic or diagnostic agent for treatment of ...
Baclofen and acamprosate based therapy of neurological disorders
Pharnext
August 17, 2017 - N°20170231958

The present invention relates to combinations and methods for the treatment of neurological disorders related to glutamate excitotoxicity and amyloid β toxicity. More specifically, the present invention relates to novel combinatorial therapies of alzheimer's disease, alzheimer's disease related disorders, amyotrophic lateral sclerosis, multiple sclerosis, parkinson's disease, huntington's disease, neuropathic pain, alcoholic neuropathy, alcoholism or alcohol withdrawal, or spinal cord ...
Products for the treatment and prevention of neurological disorders coursing with a cognition deficit or ...
FundaciÓn Para La InvestigaciÓn MÉdica Aplicada
August 17, 2017 - N°20170231931

The invention relates to a product that comprises a compound of formula (1-01) to (1-47) and a compound of formula (2-01) to (2-26), or their pharmaceutically or veterinary acceptable salts thereof, or any stereoisomers either of the compounds or of any of their pharmaceutically or veterinary acceptable salts. The invention also relates to said product for use in the treatment ...
Neurological Patent Pack
Download 364+ patent application PDFs
Neurological Patent Applications
Download 364+ Neurological-related PDFs
For professional research & prior art discovery
inventor
  • 364+ full patent PDF documents of Neurological-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Neuroarthromyofascial enhancement wear
Granite Sports Institute, Llc
August 17, 2017 - N°20170231793

A garment for enhancing neuroarthromyofascial performance in an individual includes fabric tension lines positioned within the garment in order to align with certain muscle groups of the individual wearing the garment. The fabric tension lines have an elasticity that imparts a force from one end of the fabric tension line to the other. This force transfers to the garment as ...
Measurement of als progression based on kinetic data
Als Therapy Development Institute
August 17, 2017 - N°20170231558

Methods and systems are disclosed for evaluating a neurological condition by employing at least one motion sensor, configured to be attached to a body appendage, a memory associated with the sensor(s) to periodically record movement data during periods of prescribed exercises; and a processor for analyzing changes in movement data over time to evaluate the progression of the neurological ...
Pharmaceutical composition containing combination extracts of moutan root bark, angelica dahurica root, bupleurum root or ...
Dong-a St Co., Ltd.
August 10, 2017 - N°20170224754

The present invention relates to a pharmaceutical composition for treating and preventing degenerative neurological disorders, containing, as an active ingredient, a mixture extract of two or more types selected from the group consisting of moutan root bark, angelica dahurica root, and bupleurum root, or a fraction thereof. Specifically, the extract of the mixture of the present invention exhibits a recovery ...
Neurological Patent Pack
Download 364+ patent application PDFs
Neurological Patent Applications
Download 364+ Neurological-related PDFs
For professional research & prior art discovery
inventor
  • 364+ full patent PDF documents of Neurological-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method for avoiding or inhibition of dyskinesia
Research Foundation Of The City University Of New York
August 10, 2017 - N°20170224643

Certain neurological disorders are treated with dopamine agonists (e. G. L-dopa) but these treatments unintentionally cause levodopa-induced dyskinesias (lids) or tardive dyskinesia. An improved treatment is described that treats the patient with both a dopamine agonist and a smoothened (smo) agonist or with a dopamine agonist and combination of a smoothened (smo) agonist together with amantadine.
System for diagnosing and treating neurological and psychological disorders
Research Foundation Of The City University Of New York
August 10, 2017 - N°20170224245

A medical system including electrodes for acquiring electroencephalography (eeg) signals, amplifiers to amplify the eeg signals, an analog-to-digital converter to generate digitalized eeg data from the eeg signals, and a processor for processing the digitalized eeg data to generate a indication of neurological or psychological symptom based on a combination selected among spectral, temporal, and spatial features of the digitalized ...
Biomarkers and methods relating to alzheimer's disease
King's College London
August 03, 2017 - N°20170219611

Alzheimer's disease, the most common cause of dementia in older individuals, is a debilitating neurodegenerative disease for which there is currently no cure. In the past, ad could only be definitively diagnosed by brain biopsy or upon autopsy after a patient died. These methods, which demonstrate the presence of the characteristic plaque and tangle lesions in the brain, are still ...
Ligands for alpha-7 nicotinic acetylcholine receptors and methods of treating neurological and inflammatory conditions
University Of Florida Research Foundation, Inc.
August 03, 2017 - N°20170217984

Compounds are provided which bind to an allosteric site on the mammalian alpha-7 nicotinic acetylcholine receptor (alpha-7 nachr) and act as positive allosteric modulators with or without allosteric agonist activity. The compounds are useful in diagnosing, preventing, or treating a variety of disorders involving cognition, learning, memory, neurodegeneration, drug addiction, inflammation, chronic pain, and neuropathic pain. The compounds also can ...
Novel compounds for use in cognition improvement
FundaciÓn Para La InvestigaciÓn MÉdica Aplicada
August 03, 2017 - N°20170217973

Novel compounds for use in cognition improvement it relates to certain compounds having a polycyclic structure and a —(c═o)nrarb moiety, wherein the polycyclic structure comprises at least three ring systems, wherein one ring system is a polycyclic ring system comprising from 2 to 4 rings; at least one ring is an aromatic ring; and wherein the structure comprises ...
Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological ...
The Johns Hopkins University
August 03, 2017 - N°20170216363

The presently disclosed subject matter provides compositions, methods, and kits for transfecting adipose-derived mesenchymal stem cells (amscs) in freshly extracted adipose tissue using nanoparticles comprising biodegradable polymers self-assembled with nucleic acid molecules. The presently disclosed subject matter also provides methods for treating a neurological disease in a patient in need thereof, the method comprising administering the amscs transfected with the ...
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
Samumed, Llc
August 03, 2017 - N°20170216299

Azaindazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an azaindazole compound or analogs thereof, in the treatment of disorders characterized by the activation of wnt pathway signaling (e. G., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by ...
Neurological Patent Pack
Download 364+ patent application PDFs
Neurological Patent Applications
Download 364+ Neurological-related PDFs
For professional research & prior art discovery
inventor
  • 364+ full patent PDF documents of Neurological-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods of using sustained release aminopyridine compositions
Acorda Therapeutics, Inc.
July 27, 2017 - N°20170209422

A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at about 12 hours and ...
Sustained release aminopyridine composition
Acorda Therapeutics, Inc.
July 27, 2017 - N°20170209421

A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 ...
Use of asparagusic acid and derivatives thereof to treat symptoms and disorders of neurological disease
Acorda Therapeutics, Inc.
July 27, 2017 - N°20170209413

Embodiments disclosed herein provide methods for treating and/or ameliorating symptoms of certain neurological diseases. The methods encompass administration of compositions comprising 1,2-dithiolane-4-carboxylic acid (asparagusic acid) and derivatives and condensation products thereof.
Macrocyclic kinase inhibitors and uses thereof
Dana-farber Cancer Institute, Inc.
July 20, 2017 - N°20170204116

The present disclosure provides macrocyclic compounds of formula (i). The provided compounds are able to bind protein kinases and may be useful in modulating (e. G., inhibiting) the activity of a protein kinase in a subject or cell and/or in treating or preventing a disease (e. G., proliferative disease, genetic disease, hematological disease, neurological disease, painful condition, psychiatric disorder, ...
Imidazolyl kinase inhibitors and uses thereof
Dana-farber Cancer Institute, Inc.
July 20, 2017 - N°20170204082

The present disclosure provides imidazolyl compounds of formula (i) and methods of preparing the compounds. The provided compounds are able to bind protein kinases and may be useful in modulating (e. G., inhibiting) the activity of a protein kinase in a subject or cell and/or in treating or preventing a disease (e. G., proliferative disease, genetic disease, hematological disease, ...
Inhibitors of histone deacetylase
Rodin Therapeutics, Inc.
July 20, 2017 - N°20170204070

This invention provides compounds that are inhibitors of hdac2. The compounds (e. G., compounds according to formula (i), (ii), (iia), (iii), (iv), (v), or (vi)) accordingly are useful for treating, alleviating, or preventing a condition in a subject such as a neurological disorder, memory or cognitive function disorder or impairment, extinction learning disorder, fungal disease or infection, inflammatory disease, hematological ...
Phenyl substituted cycloalkylamines as monoamine reputake inhibitors
Sunovion Pharmaceuticals Inc.
July 20, 2017 - N°20170204050

Phenyl-substituted cyclohexylamine derivatives and methods for their synthesis and characterization are disclosed. Use of these compounds to treat/prevent neurological disorders as well as methods for their synthesis are set forth herein. Exemplary compounds of the invention inhibit reuptake of endogenous monoamines, such as dopamine, serotonin and norepinephrine (e. G., from the synaptic cleft) and modulate one or more monoamine ...
Novel enteric combination therapy
Sunovion Pharmaceuticals Inc.
July 20, 2017 - N°20170202905

There is disclosed herein a composition for treating gastrointestinal or neurological disorders, constipation, functional constipation, irritable bowel syndrome, diverticulitis, travelers diarrhea, chronic idiopathic nausea, ibd-associated constipation and diarrhea, pseudo-obstruction, diabetic gastroparesis, cyclic vomiting, reflux oesophagitis, autism enteropathy, flatulence, halitosis, chronic fatigue, bloating, proctalgia fugax, parkinsons disease, ms, alzheimers disease, motor neurone disease or autism, the composition comprising: (i) at least ...
Loading